WASHINGTON (AP) — A new strategy to fight an extremely aggressive type of brain tumor showed promise in a pair of experiments with a handful of patients. Scientists took patients’ own immune cells and turned them into “living drugs” able to recognize and attack glioblastoma. In the first-step tests, those cells shrank tumors at least temporarily, researchers reported Wednesday. So-called CAR-T therapy already is used to fight blood-related cancers like leukemia but researchers have struggled to make it work for solid tumors. Now separate teams at Massachusetts General Hospital and the University of Pennsylvania are developing next-generation CAR-T versions designed to get past some of glioblastoma’s defenses. “It’s very early days,” cautioned Penn’s Dr. Stephen Bagley, who led one of the studies. But “we’re optimistic that we’ve got something to build on here, a real foundation.” |
Trump will speak at the Libertarian National Convention as he woos independent votersBiden administration weighing measures to help Palestinians bring family from regionDonald Trump's glamorous aide Margo Martin looks stylish as she heads to court with him in a figureBaby Reindeer stars Richard Gadd and Jessica Gunning are armEvan Mobley has huge block in final seconds as Cavaliers hold off Banchero, Magic 104Trump will speak at the Libertarian National Convention as he woos independent votersWant to spend the night in a Paris museum or a house owned by Prince? Airbnb plans to list themSelena Gomez reveals why she quit Instagram for four yearsWhat are the most memorable Kentucky Derby races?Kim Kardashian shows off her curves and continues to plug controversial $60k Cybertruck